Clinical observations on infliximab treatment of infantile onset Takayasu arteritis

Clinical observations on infliximab treatment of infantile onset Takayasu arteritis

Abstract Background There is insufficient evidence on the clinical effectiveness and safety of infliximab (IFX) treatment of Takayasu arteritis (TA) in infants. Methods We evaluated the therapeutic effectiveness and safety of IFX in a retrospective case series of 10 infantile TA patients. Observatio...

Full description

Bibliographic Details
Main Authors: Min Kang, Jianming Lai, Dan Zhang, Yingjie Xu, Jia Zhu, Ming Li
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Takayasu arteritis
Infants
Infliximab
Effectiveness
Safety
Online Access:https://doi.org/10.1186/s12969-022-00708-4

Internet

https://doi.org/10.1186/s12969-022-00708-4

Similar Items